Current Report Filing (8-k)
May 17 2013 - 5:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported): May 13, 2013
CytoDyn Inc.
(Exact name of registrant as specified in charter)
Colorado
(State or other jurisdiction of incorporation)
000-49908
(SEC File Number)
75-3056237
(IRS Employer Identification No.)
|
|
|
5 Centerpointe Drive, Suite 400
Lake Oswego, Oregon |
|
97035 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (971) 204-0382
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
(b) |
Effective May 13, 2013, Allan M. Green resigned as a director of CytoDyn Inc. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
CytoDyn Inc. |
|
|
|
Dated: May 17, 2013 |
|
By: |
|
/s/ Michael D. Mulholland |
|
|
|
|
Michael D. Mulholland Chief
Financial Officer |
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Jun 2024 to Jul 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Jul 2023 to Jul 2024